Theories of Aging

  • Stanley Muravchick


“Gerontology” refers to the application of the various scientific disciplines to the study of aging. Aging manifests itself in most organisms as a gradual decline in the capacity to maintain anabolic processes or to respond to environmental change. Degenerative changes in both the physical structure and the functional capacity of organs and tissues are the clinical characteristics of human aging. In all species, regardless of how aging makes itself apparent, the implied consequence of aging is an increased probability of death as a function of time.


Reactive Oxygen Species Caloric Restriction Mammalian Aging Biologic Order Central Nervous System Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Carel A. On the permanent life of tissues outside of the organism. J Exp Med 1912;15:516–528.CrossRefGoogle Scholar
  2. 2.
    Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;57:614–636.CrossRefGoogle Scholar
  3. 3.
    Hayflick L. Biologic and theoretical perspectives of human aging. In: Katlic MR, ed. Geriatric Surgery: Comprehensive Care of the Elderly Patient. Baltimore: Urban and Schwarzenberg; 1990:3–21.Google Scholar
  4. 4.
    Hayflick L. The biology of human aging. Am J Med Sci 1973; 265:433–445.CrossRefGoogle Scholar
  5. 5.
    Strehler BL. Aging: concepts and theories. In: Viidik A, ed. Lectures on Gerontology. New York: Academic Press; 1982: 1–57.Google Scholar
  6. 6.
    Gershon H, Gershon D. Paradigms in aging research: a critical review and assessment. Mech Ageing Dev 2000;117: 21–28.PubMedCrossRefGoogle Scholar
  7. 7.
    Bidder GP. Senescence. Br Med J 1932;15:5831.Google Scholar
  8. 8.
    Ameisen JC. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Diff 2002;9:367–393.CrossRefGoogle Scholar
  9. 9.
    Troen BR. The biology of aging. Mt Sinai J Med 2003;70: 3–22.PubMedGoogle Scholar
  10. 10.
    Kirkwood TB. Sex and ageing. Exp Gerontol 2001;36:413–418.PubMedCrossRefGoogle Scholar
  11. 11.
    Sacher GA. Molecular versus systemic theories on the genesis of aging. Exp Gerontol 1968;3:265–271.PubMedCrossRefGoogle Scholar
  12. 12.
    de Magalhaes JP, Toussaint O. The evolution of mammalian aging. Exp Gerontol 2002;37:769–775.PubMedCrossRefGoogle Scholar
  13. 13.
    Partridge L. Evolutionary theories of ageing applied to long-lived organisms. Exp Gerontol 2001;36:641–650.PubMedCrossRefGoogle Scholar
  14. 14.
    Finch CE. Neuroendocrine mechanisms and aging. Fed Proc 1979;38:178–183.PubMedGoogle Scholar
  15. 15.
    Harman D. Aging: overview. Ann NY Acad Sci 2001;928: 1–21.PubMedGoogle Scholar
  16. 16.
    Strehler BL. Genetic instability as the primary cause of human aging. Exp Gerontol 1986;21:283–319.PubMedCrossRefGoogle Scholar
  17. 17.
    Toussaint O, Schneider ED. The thermodynamics and evolution of complexity in biological systems. Comp Biochem Physiol A Molec Integr Physiol 1998;120:3–9.CrossRefGoogle Scholar
  18. 18.
    Orgel LE. The maintenance of the accuracy of protein synthesis and its relevance to ageing. Proc Natl Acad Sci USA 1963;49:517–521.PubMedCrossRefGoogle Scholar
  19. 19.
    Orgel LE. The maintenance of the accuracy of protein synthesis and its relevance to ageing: a correction. Proc Natl Acad Sci USA 1970;67:1476.PubMedCrossRefGoogle Scholar
  20. 20.
    Stadtman ER. Protein oxidation in aging and age-related diseases. Ann NY Acad Sci 2001;928:22–38.PubMedGoogle Scholar
  21. 21.
    Lee AT, Cerami A. Role of glycation in aging. Ann NY Acad Sci 1992;663:63–70.PubMedCrossRefGoogle Scholar
  22. 22.
    Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001;56:1–21.PubMedCrossRefGoogle Scholar
  23. 23.
    Al Abed Y, Mitsuhashi T, Li H, et al. Inhibition of advanced glycation end product formation by acetaldehyde: role in the cardioprotective effect of ethanol. Proc Natl Acad Sci USA 1999;96:2385–2390.CrossRefGoogle Scholar
  24. 24.
    Vaitkevicius PV, Lane M, Spurgeon H, et al. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys. Proc Natl Acad Sci USA 2001;98:1171–1175.PubMedCrossRefGoogle Scholar
  25. 25.
    Reznick AZ, Lavie L, Gershon HE, et al. Age-associated accumulation of altered FDP aldolase B in mice: conditions of detection and determination of aldolase half life in young and old animals. FEBS Lett 1981;128:221–224.PubMedCrossRefGoogle Scholar
  26. 26.
    Stolzing A, Grune T. The proteasome and its function in the ageing process. Clin Exp Dermatol 2001;26:566–572.PubMedCrossRefGoogle Scholar
  27. 27.
    Gray DA, Tsirigotis M, Woulfe J. Ubiquitin, proteasomes, and the aging brain. Sci Aging Knowledge Environ 2003: 2003(34):RE6.PubMedCrossRefGoogle Scholar
  28. 28.
    Ahmed A, Tollefsbol T. Telomeres and telomerase: basic science implications for aging. J Am Geriatr Soc 2001;49: 1105–1109.PubMedCrossRefGoogle Scholar
  29. 29.
    Gallagher M, Colombo PJ. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 1995;5: 161–168.PubMedCrossRefGoogle Scholar
  30. 30.
    Yew DT, Li WP, Webb SE, et al. Neurotransmitters, pep tides, and neural cell adhesion molecules in the cortices of normal elderly humans and Alzheimer patients: a comparison. Exp Gerontol 1999;34:117–133.PubMedCrossRefGoogle Scholar
  31. 31.
    McGeer EG, McGeer PL. Age changes in the human for some enzymes associated with metabolism of catecholamines, GAB A, and acetylcholine. Adv Behav Biol 1975;16: 287–305.Google Scholar
  32. 32.
    Munson ES, Hoffman JC, Eger EI II. Use of cyclopropane to test generality of anesthetic requirement in the elderly. Anesth Analg 1984;63:998–1000.PubMedCrossRefGoogle Scholar
  33. 33.
    Nagy IZ. On the true role of oxygen free radicals in the living state, aging, and degenerative disorders. Ann NY Acad Sci 2001;928:187–199.PubMedCrossRefGoogle Scholar
  34. 34.
    Sohal RS, Weindruch R. Oxidative stress, caloric restriction, and aging. Science 1996;273:59–63.PubMedCrossRefGoogle Scholar
  35. 35.
    Knight JA. The biochemistry of aging. Adv Clin Chem 2000; 35:1–62.PubMedCrossRefGoogle Scholar
  36. 36.
    Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation, and impairment of antioxidant enzymes in aging. Exp Biol Med 2002;227:671–682.Google Scholar
  37. 37.
    Jendrach M, Pohl S, Voth M, Kowald A, Hammerstein P, Bereiter-Hahn J. Morpho-dynamic changes of mitochondria during ageing of human endothelial cells. Mech Ageing Dev 2005;126:813–821.PubMedCrossRefGoogle Scholar
  38. 38.
    Golden TR, Melov S. Mitochondrial DNA mutations, oxidative stress, and aging. Mech Ageing Dev 2001;122: 1577–1589.PubMedCrossRefGoogle Scholar
  39. 39.
    Rattan SI. Ageing, gerontogenes, and hormesis. Indian J Exp Biol 2000;38:1–5.PubMedGoogle Scholar
  40. 40.
    Skulachev VP. Programmed death phenomena: from organelle to organism. Ann NY Acad Sci 2002;959:214–237.PubMedGoogle Scholar
  41. 41.
    Mangel M. Complex adaptive systems, aging and longevity. J Theor Biol 2001;213:559–571.PubMedCrossRefGoogle Scholar
  42. 42.
    Lithgow GJ, Walker GA. Stress resistance as a determinate of C. elegans lifespan. Mech Ageing Dev 2002;123:765–771.PubMedCrossRefGoogle Scholar
  43. 43.
    Herrero A, Barja G. H2O2 production of heart mitochondria and aging rate are slower in canaries and parakeets than in mice: sites of free radical generation and mechanisms involved. Mech Ageing Dev 1998;103:133–146.PubMedCrossRefGoogle Scholar
  44. 44.
    Holmes DJ, Fluckiger R, Austad SN. Comparative biology of aging in birds: an update. Exp Gerontol 2001; 36:869–883.PubMedCrossRefGoogle Scholar
  45. 45.
    Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004;429:417–423.PubMedCrossRefGoogle Scholar
  46. 46.
    Kapahi P, Boulton ME, Kirkwood TB. Positive correlation between mammalian life span and cellular resistance to stress. Free Radic Biol Med 1999;26:495–500.PubMedCrossRefGoogle Scholar
  47. 47.
    Mandavilli BS, Santos JH, Van Houten B. Mitochondrial DNA repair and aging. Mutat Res 2002;509:127–151.PubMedGoogle Scholar
  48. 48.
    Sugiyama S, Hattori K, Hayakawa M, et al. Quantitative analysis of age-associated accumulation of mitochondrial DNA with deletion in human hearts. Biochem Biophys Res 1991;180:894–899.CrossRefGoogle Scholar
  49. 49.
    Barja G, Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J 2000;14:312–318.PubMedGoogle Scholar
  50. 50.
    Masoro EJ, Bertrand H, Liepa G, et al. Analysis and exploration of age-related changes in mammalian structure and function. Fed Proc 1979;38:1956–1961.PubMedGoogle Scholar
  51. 51.
    Barja G. Endogenous oxidative stress: relationship to aging, longevity and caloric restriction. Ageing Res Rev 2002;1: 397–411.PubMedCrossRefGoogle Scholar
  52. 52.
    Lee C-K, Klopp RG, Weindruch R, et al. Gene expression profile of aging and its retardation by caloric restriction. Science 1999;285:1390–1392.PubMedCrossRefGoogle Scholar
  53. 53.
    Heininger K. Aging is a deprivation syndrome driven by a germ-soma conflict. Ageing Res Rev 2002;1:481–536.PubMedCrossRefGoogle Scholar
  54. 54.
    Huang H, Manton KG. The role of oxidative damage in mitochondria during aging: a review. Front Biosci 2004;9: 1100–1117.PubMedCrossRefGoogle Scholar
  55. 55.
    Lieber MR, Karanjawala ZE. Ageing, repetitive genomes and DNA damage. Nat Rev Mol Cell Biol 2004;5:69–75.PubMedCrossRefGoogle Scholar
  56. 56.
    Maklashina E, Ackrell BA. Is defective electron transport at the hub of aging? Aging Cell 2004;3:21–27.PubMedCrossRefGoogle Scholar
  57. 57.
    Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 2005;38:1543–1552.PubMedCrossRefGoogle Scholar
  58. 58.
    Immenschuh S, Baumgart-Vogt E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal 2005;7:768–777.PubMedCrossRefGoogle Scholar
  59. 59.
    Bayne AC, Mockett RJ, Orr WC, Sohal RS. Enhanced catabolism of mitochondrial superoxide/hydrogen peroxide and aging in transgenic Drosophila. Biochem J 2005;391(Pt 2): 277–284.PubMedCrossRefGoogle Scholar
  60. 60.
    Nascher IL. Geriatrics. NY Med J 1909;90:358–359.Google Scholar
  61. 61.
    Hofman MA. Energy metabolism, brain size and longevity in mammals. Q Rev Biol 1983;58:495–512.PubMedCrossRefGoogle Scholar
  62. 62.
    Schneider EL, Reed JD Jr. Life extension. N Engl J Med 1985;312:1159–1168.PubMedGoogle Scholar
  63. 63.
    Comfort A. The Biology of Senescence. 3rd ed. New York: Elsevier; 1979:414 pp.Google Scholar
  64. 64.
    Fries JF. Aging, natural death, and the compression of morbidity. N Engl J Med 1980;303:130–135.PubMedGoogle Scholar
  65. 65.
    Hofer SM, Sliwinski MJ. Understanding ageing: an evaluation of research designs for assessing the interdependence of ageing-related changes. Gerontology 2001;47:341–352.PubMedCrossRefGoogle Scholar
  66. 66.
    Ozawa T. Genetic and functional changes in mitochondria associated with aging. Physiol Rev 1997;77:425–464.PubMedGoogle Scholar
  67. 67.
    Calabrese V, Scapagnini G, Giuffrida Stella AM, et al. Mitochondrial involvement in brain function and dysfunction: relevance to aging, neurodegenerative disorders and longevity. Neurochem Res 2001;26:739–764.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Stanley Muravchick
    • 1
  1. 1.Department of Anesthesiology and Critical CareHospital of the University of PennsylvaniaPhiladelphiaUSA

Personalised recommendations